Transcripta Bio
About Transcripta Bio
Transcripta Bio is a Therapeutics startup based in Palo Alto, CA, United States that has raised $34M in venture capital across 2 funding rounds since 2020. The company reached Series A stage in April 2024 with a $10M round led by institutional investors. Transcripta Bio's investor base includes 4 institutional funds, with Mayo Clinic leading the most recent equity round.
Transcripta Bio (formerly Rarebase) is an AI-powered drug discovery company that uses full transcriptomic resolution to map how diseases and drugs affect gene expression across thousands of genes simultaneously. The platform combines a Disease Signature Atlas, a Drug-Gene Atlas, and Conductor AI to systematically identify drug candidates that reverse disease-specific transcriptomic patterns. The company is building a pipeline targeting neurological and neuromuscular conditions including Autism Spectrum Disorder, Facioscapulohumeral Muscular Dystrophy, Huntington's Disease, and Myotonic Dystrophy.
Transcripta Bio Funding Rounds Timeline
2 rounds · $34M raised · since 2020
| Round | Date | Amount | Valuation | Lead investor | Co-investors |
|---|---|---|---|---|---|
| Series A | April 2024 | $10M | — | — | JAZZ Venture Partners, BlueYard Capital |
| Series A Extension | July 2026 | $24M | — | Mayo Clinic | Omnimed, JAZZ Venture Partners, BlueYard Capital |
Investors in Transcripta Bio
4 institutional investors across 2 rounds
Lead investors
Co-investors
Recent news about Transcripta Bio
- FundingTranscripta Bio Announces $24 Million FundingJuly 2026
Questions about Transcripta Bio
How much has Transcripta Bio raised?
Transcripta Bio has raised $34M across 2 funding rounds since 2020.
Who are the investors of Transcripta Bio?
Transcripta Bio's investors include Mayo Clinic, JAZZ Venture Partners, BlueYard Capital, Omnimed.
When was Transcripta Bio's last funding round?
Transcripta Bio's most recent round was a $10M Series A in April 2024.
Where is Transcripta Bio headquartered?
Transcripta Bio is headquartered in Palo Alto, CA, United States, and was founded in 2020 by Onno Faber, Chris Moxham.